FDA recall, , Moderate risk
American National Red Cross Red Blood Cells
American National Red Cross Red Blood Cells, for which Babesia testing was not performed, were distributed.
Recall ended Feb 6, 2026. Still check yours.
Summary by Recall Canary from the FDA notice
What happened
The American National Red Cross began a recall on May 10, 2023, for Red Blood Cells and Apheresis Red Blood Cells, Leukocytes Reduced, for which Babesia testing was not performed, and which were distributed to states including Alabama, California, Colorado, Connecticut, Georgia, Iowa, Kansas, Massachusetts, Maryland, Maine, Minnesota, Mississippi, Montana, Nebraska, New Hampshire, New Jersey, New York, Pennsylvania, South Carolina, Texas, Virginia, Vermont, Wisconsin, Puerto Rico and U.S. Virgin Islands.
2 photos
What to do
We don't have product-specific instructions for this recall. FDA's general advice for medicine recalls:
- Check the FDA or company notice for instructions specific to this product.
- Ask your pharmacist or doctor whether your lot is affected and what to do.
Is yours affected?
5 products
Compare these details with yours, then check the recall notice to see which units are recalled.
Red Blood Cells, Leukocytes Reduced
Reason: Red Blood Cells, Leukocytes Reduced, for which Babesia testing was not performed, were distributed.
Apheresis Red Blood Cells, Leukocytes Reduced
Reason: Apheresis Red Blood Cells, Leukocytes Reduced, for which Babesia testing was not performed, were distributed.
- Affected units
- W20172144262700P; W20172015416300H (double collection); W20172142441200D (double collection); W20172015416000N (double collection); W20172142442000D (double collection); W20172142638300X (double collection); W201723030167002 (double collection); W201723030159002 (double collection); W201723009039007 (double collection); W20172300903300J (double collection); W20172142639100X (double collection); W20172300903000P (double collection); W20172300902200P (double collection); W20172144265700D (double collection); W20172144265400J (double collection); W20172144264200R (double collection); W20172144262800N (double collection); W20172142639700L (double collection); W20172144262400V (double collection)
Red Blood Cells, Leukocytes Reduced, Irradiated
Reason: Red Blood Cells, Leukocytes Reduced, Irradiated, for which Babesia testing was not performed, were distributed.
Red Blood Cells, Washed, Leukocytes Reduced, Irradiated
Reason: Red Blood Cells, Washed, Leukocytes Reduced, Irradiated, for which Babesia testing was not performed, were distributed.
Red Blood Cells, Frozen, Leukocytes Reduced, Irradiated
Reason: Red Blood Cells, Frozen, Leukocytes Reduced, Irradiated, for which Babesia testing was not performed, were distributed.
Recall details
- Company began the recall
- Sold in
- 23 states and 2 territories
- Company
- The American National Red Cross
- Hazard
- Quality testing problem
- Risk
Moderate risk
Taking it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.
FDA Class II recall · How risk is rated
- Event ID
- 98405
- Recall numbers
- B-0012-2026 to B-0016-2026
All recalls from The American National Red Cross
Timeline
FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.
Company began the recall
Added to FDA's Enforcement Report · Classified by FDA · Recall ended
In FDA's weekly enforcement report
Listed on Recall Canary
Archived
